Home
Scholarly Works
O4 Comorbidity, age and performance status are...
Conference

O4 Comorbidity, age and performance status are important predictors of outcome in older multiple myeloma patients treated with melphalan and corticosteroids: subgroup analysis from the National Cancer Institute of Canada MY7 trial

Authors

Kouroukis CT; Hafid T; Wong J; Kovacs MJ; Barr R; Findlay B; Shepherd L; Djurfeldt M; Ding K; Zhu L

Volume

72

Pagination

pp. s15-s16

Publisher

Elsevier

Publication Date

October 1, 2009

DOI

10.1016/s1040-8428(09)70031-9

Conference proceedings

Critical Reviews in Oncology/Hematology

Issue

1

ISSN

1040-8428

Contact the Experts team